SCHEMBL7225865

SCHEMBL7225865

O=C(O)[C@H]1CCCC[C@@H]1Cc1ccc(F)c(F)c1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 2/20 0.47
PTGS2 P35354 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.45
TAAR1 Q96RJ0 1/20 0.43
GLA P06280 1/20 0.42
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
CA9 Q16790 2/20 0.42
CA12 O43570 1/20 0.42
HTT P42858 1/20 0.41
ALDH1A1 P00352 3/20 0.40
CASP1 P29466 1/20 0.40
HSD17B10 Q99714 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
SIGMAR1 Q99720 2/20 0.38
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7221456 0.80 SMN1; SMN2 (0.44) PTGS1PTGS2SMN1; SMN2TAAR1GLA
SCHEMBL7452648 0.78 TAAR1 (0.53) SMN1; SMN2TAAR1GLAALDH1A1L3MBTL1
SCHEMBL7230439 0.78 TAAR1 (0.53) SMN1; SMN2TAAR1GLAALDH1A1L3MBTL1
SCHEMBL7452644 0.78 TAAR1 (0.53) SMN1; SMN2TAAR1GLAALDH1A1L3MBTL1
SCHEMBL188674 0.75 PTGS1 (0.41) PTGS1PTGS2ALDH1A1L3MBTL1SIGMAR1
SCHEMBL7223358 0.74 HSD17B10 (0.56) PTGS1PTGS2TAAR1ALDH1A1HSD17B10
SCHEMBL5002695 0.74 HSD17B10 (0.56) PTGS1PTGS2TAAR1ALDH1A1HSD17B10
SCHEMBL3165178 0.72 GRM2 (0.50) CA1CA2CA9CA12HTT
SCHEMBL4579456 0.72 CYP2C9 (0.49) PTGS1PTGS2TAAR1CA1CA2
SCHEMBL16191209 0.71 ALDH1A1 (0.49) HTTALDH1A1MEN1KMT2ACNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6545160-B2 Alpha-aminoacetic acid derivatives bind alpha 4 beta 7 integrin, useful for treatment of inflammatory diseases in mammalian patient, such as asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, rheumatoid arthritis ELAN PHARMACEUTICALS, INC. 2003-04-08 US disclosed